« Previous
Next »
Titles
- Illinois Medicaid Fraud Control Unit: 2019 onsite review1
- Illuminating the Impact of COVID-19 on hospitals and health systems: a comparative study of revenue and utilization1
- Illustrating the harmful impact of Medicaid block grants and per capita caps on state funding of K-12 education1
- Immigration detention: ICE efforts to address COVID-19 in detention facilities : report to Congressional committees1
- Immigration detention: care of pregnant women in DHS facilities : report to Congressional requesters1
- Impact of the COVID-19 pandemic on primary care practices1
- Impacts of the ACA’s Medicaid expansion on health insurance coverage and health care access among young adults1
- Implanted brain-computer interface (BCI) devices for patients with paralysis or amputation: non-clinical testing and clinical considerations : guidance for industry and Food and Drug Administration staff1
- Implications of CMS's new "Healthy Adult Opportunity" demonstrations for Medicaid1
- Importation of certain FDA approved human prescription drugs, including biological products, and combination products under section 801(d)(1)(b) of the Federal Food, Drug, and Cosmetic Act1
- Improving COVID-19 outcomes for Medicare beneficiaries: a public health–supported advanced primary care paradigm1
- Improving antibiotic use through collaboration among clinicians, researchers, and Medicaid1
- Improving data on race and ethnicity: a roadmap to measure and advance health equity1
- Improving evidence-based policymaking: a review1
- Improving food and nutrition security during COVID-19, the economic recovery, and beyond1
- Improving nutrition and infant health through WIC: opportunities during and beyond a public health crisis1
- Improving opportunities for working people with disabilities1
- Improving patient and provider experiences to advance maternal health equity: strategies to address inequity during the COVID-19 pandemic and beyond1
- In their own words: how fragmented care harms people with both mental illness and substance use disorder2
- In vitro drug interaction studies: cytochrome P-450 enzyme- and transporter-mediated drug interactions1